http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-614904-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bba710e7aaa56d8ab15a910fcd3dc5f
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
filingDate 2009-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5637fc7d923173c68020ac6534c3bd6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3354a785562b6750592e2bde0c86b8fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d956fae356a3b7fd3315e3999df88213
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fc78c739c1a645731a538a4c7c4d0ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9651a5280cdca7f656e8d1b88b349cae
publicationDate 2015-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NZ-614904-A
titleOfInvention Mlk inhibitors and methods of use
abstract Disclosed are compounds of formula (I) having an inhibitory effect on Mixed Lineage Kinases (MLK). Also provided are pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by Mixed Lineage Kinase inhibition. Also provided are methods of treatment of neuropsychiatric disorders which comprise the inhibition of Mixed Lineage Kinases. Examples of compounds of formula (I) are: 2-phenyl-N-{ 4-[5-(3,4,5-trimethoxy-phenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-benzyl} -acetamide and 3-phenyl-N-{ 4-[5-(3,4,5-trimethoxy-phenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-benzyl} -propionamide.
priorityDate 2008-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421346904
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID607170
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID404626
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422147832
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID451940
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25579
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54764744
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66779391
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID505427
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7786
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID26404

Total number of triples: 28.